Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity.

Julik E, Reyes-Del Valle J.

Viruses. 2017 Sep 21;9(10). pii: E265. doi: 10.3390/v9100265.

2.

Molecular engineering and plant expression of an immunoglobulin heavy chain scaffold for delivery of a dengue vaccine candidate.

Kim MY, Van Dolleweerd C, Copland A, Paul MJ, Hofmann S, Webster GR, Julik E, Ceballos-Olvera I, Reyes-Del Valle J, Yang MS, Jang YS, Reljic R, Ma JK.

Plant Biotechnol J. 2017 Dec;15(12):1590-1601. doi: 10.1111/pbi.12741. Epub 2017 Jul 15.

3.

Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.

Julik E, Reyes-Del Valle J.

J Virol. 2016 May 12;90(11):5270-5279. doi: 10.1128/JVI.00348-16. Print 2016 Jun 1.

4.

Novel vaccination approach for dengue infection based on recombinant immune complex universal platform.

Kim MY, Reljic R, Kilbourne J, Ceballos-Olvera I, Yang MS, Reyes-del Valle J, Mason HS.

Vaccine. 2015 Apr 8;33(15):1830-8. doi: 10.1016/j.vaccine.2015.02.036. Epub 2015 Feb 26.

PMID:
25728317
5.

Dengue vaccines: strongly sought but not a reality just yet.

del Angel RM, Reyes-del Valle J.

PLoS Pathog. 2013;9(10):e1003551. doi: 10.1371/journal.ppat.1003551. Epub 2013 Oct 3. Review. No abstract available.

6.

Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster.

Reyes-del Valle J, de la Fuente C, Turner MA, Springfeld C, Apte-Sengupta S, Frenzke ME, Forest A, Whidby J, Marcotrigiano J, Rice CM, Cattaneo R.

J Virol. 2012 Nov;86(21):11558-66. doi: 10.1128/JVI.01776-12. Epub 2012 Aug 15.

7.

A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys.

Devaux P, Hudacek AW, Hodge G, Reyes-Del Valle J, McChesney MB, Cattaneo R.

J Virol. 2011 Jan;85(1):348-56. doi: 10.1128/JVI.00802-10. Epub 2010 Oct 27.

8.

Images in clinical medicine. A foreign body.

Flores-Suarez R, Reyes-del Valle J.

N Engl J Med. 2010 Oct 28;363(18):1748. doi: 10.1056/NEJMicm0707656. No abstract available.

9.

Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys.

Leonard VH, Hodge G, Reyes-Del Valle J, McChesney MB, Cattaneo R.

J Virol. 2010 Apr;84(7):3413-20. doi: 10.1128/JVI.02304-09. Epub 2010 Jan 13.

10.

Protective anti-hepatitis B virus responses in rhesus monkeys primed with a vectored measles virus and boosted with a single dose of hepatitis B surface antigen.

Reyes-del Valle J, Hodge G, McChesney MB, Cattaneo R.

J Virol. 2009 Sep;83(17):9013-7. doi: 10.1128/JVI.00906-09. Epub 2009 Jun 17.

11.

Heat shock effect upon dengue virus replication into U937 cells.

Chavez-Salinas S, Ceballos-Olvera I, Reyes-Del Valle J, Medina F, Del Angel RM.

Virus Res. 2008 Dec;138(1-2):111-8. doi: 10.1016/j.virusres.2008.08.012. Epub 2008 Oct 7.

PMID:
18809444
12.

Evidence that the 45-kD glycoprotein, part of a putative dengue virus receptor complex in the mosquito cell line C6/36, is a heat-shock related protein.

Salas-Benito J, Reyes-Del Valle J, Salas-Benito M, Ceballos-Olvera I, Mosso C, del Angel RM.

Am J Trop Med Hyg. 2007 Aug;77(2):283-90.

PMID:
17690400
13.

Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells.

Reyes-Del Valle J, Chávez-Salinas S, Medina F, Del Angel RM.

J Virol. 2005 Apr;79(8):4557-67.

14.

Isolation of putative dengue virus receptor molecules by affinity chromatography using a recombinant E protein ligand.

Reyes-del Valle J, del Angel RM.

J Virol Methods. 2004 Mar 1;116(1):95-102.

PMID:
14715312
15.

Cellular proteins from human monocytes bind to dengue 4 virus minus-strand 3' untranslated region RNA.

Yocupicio-Monroy RM, Medina F, Reyes-del Valle J, del Angel RM.

J Virol. 2003 Mar;77(5):3067-76.

Supplemental Content

Loading ...
Support Center